Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group (Q53753081)
scientific article
Language:
Current Data About Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group
(P31) (Q13442814)
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

(P50) (Q38323212)
(P1932) R Wunderink
(P1545) 2

(P304) 934-941
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

(P407) (Q1860)

(P433) 12
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

(P478) 273
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

(P577) Wednesday, March 1, 1995
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

(P921) (Q181600)

(Q18032037)

(Q6934595)
(P887)

(Q79460)
(P887)

(Q183134)
(P887)

(Q422248)
(P887)

(P1433) (Q1470970)
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

(P1476) "Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group" (language: en)
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

(P2093) E Abraham
(P1545) 1
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

H Silverman
(P1545) 3
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

T M Perl
(P1545) 4
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

S Nasraway
(P1545) 5
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

H Levy
(P1545) 6
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

R Bone
(P1545) 7
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

R P Wenzel
(P1545) 8
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

R Balk
(P1545) 9
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

R Allred
(P1545) 10
(P248)
(P698) 7884952
(P813) Saturday, May 19, 2018
(P854) http://europepmc.org/abstract/MED/7884952

other details
description scientific article

External Links
(P356) 10.1001/JAMA.1995.03520360048038
(P698) 7884952